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Effects of methylprednisolone on glomerular and medullary mRNA
levels for extracellular matrices in puromycin aminonucleoside nephrosis.
We examined the effects of methylprednisolone (MPSL) on type IV
collagen, laminin and heparan sulfate proteoglycan (HSPG) mRNA
levels in the renal glomeruli and medulla of puromycin aminonucleoside
(PAN) nephrosis. mRNA levels encoding for type LV collagen and
laminin increased markedly, whereas those for HSPG decreased signif-
icantly in glomeruli of PAN nephrosis. Administration of MPSL par-
tially ameliorated the abnormal gene expression for basement mem-
brane components. Furthermore, we showed that medullary mRNA
levels for all these basement membrane components decreased with age
in PAN nephrosis with or without MPSL treatment, suggesting that
neither PAN nor MPSL has any effect on basement membrane compo-
nent mRNA levels in the renal medulla. In contrast, mRNA levels for
the interstitial collagens including al (1) and al (ILL) chains in glomeruli
showed little change with or without MPSL treatment, whereas those in
medulla increased significantly in PAN nephrosis when compared with
the control. MPSL ameliorated the abnormal gene expression of al (I)
and al (III) collagen in renal medulla. These results indicate that PAN
affects both glomerular mRNA encoding for basement membrane
components and medullary mRNA encoding for interstitial collagens,
and that MPSL has marked effects on the amelioration of abnormal
gene expression in both glomeruli and medulla of PAN nephrosis
Basement membranes are extracellular matrices which sepa-
rate epithelial and endothelial cells from the underlying stroma
[1, 2]. Recent studies have shown that basement membrane is
formed by the coassembly of type IV collagen with a triple
helical filament of two al chains and one a2 chain [3], laminin
with a cruciform-shaped glycoprotein [4] composed of A, B 1
and B2 chains, and heparan sulfate proteoglycan (HSPG),
consisting of one chain with two to three glycosaminoglycans
attached to one end [5]. Type I and III collagens are the
predominant collagens in interstitial tissues and both collagens
show similar tissue distributions [6]. However, little is known
about the synthesis and degradation of these basement mem-
brane components and interstitial collagens in glomeruli and
medulla because of difficulties in isolating and solubilizing the
basement membrane and mesangium [7].
The identification and characterization of cDNAs coding for
basement membrane components including al (IV), laminin
and HSPG and for interstitial coLlagens including al (I) and al
(III) have provided a highly sensitive and specific means by
which the transcription of extracellular matrix (ECM) proteins
can be examined in glomeruli and medulla, namely, assaying
the steady-state mRNA levels coding for these proteins [81.
Puromycin aminonucleoside (PAN) nephrosis in rats is an
established model of minimal change disease [9, 10]. Although
this disease has been extensively studied for more than three
decades, the pathogenesis is still obscure. In a previous study
[11], we showed the abnormal gene expression of al (IV),
laminin and HSPG in glomeruli of PAN nephrosis and indicated
that decreased HSPG mRNA levels might contribute to the
development of proteinuria. Eddy et a! [12] have demonstrated
significant changes in the interstitium of kidneys in rats given a
single intraperitoneal injection of PAN. It is well known that the
administration of steroid to PAN rats results in the rapid
disappearance of proteinuria and significantly faster recovery of
histological changes [131. A recent study has demonstrated that
dexamethasone increases the HSPG core protein content of
glomerular epithelial cells [14]. Ohyama et a! [15] demonstrated
that steady state levels of mRNA encoding for al (I) and al (III)
chains were reduced by dexamethasone in cultured mesangial
cells.
However, little is known about the in vivo effect of methyl-
prednisolone (MPSL) on mRNA levels for ECM components
and interstitial collagens in glomeruli and/or medulla of PAN
nephrosis.
The purpose of this study was to determine whether MPSL
affects the gene expression of basement membrane components
and interstitial collagens in the glomeruli and medulla of PAN
nephrosis.
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Animal models
Two hundred male Sprague-Dawley rats, weighting 150 to
200 g, were used for this study. They were housed in individual
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metabolic cages and had free access to food and water through-
out the experiments. One hundred rats were made nephrotic by
a single intraperitoneal injection of 15 mgIlOO g body weight of
puromycin aminonucleoside (Sigma Chemical Co., St. Louis,
Missouri, USA). The other 100 rats were used as controls.
Methylprednisolone (Upjohn Co., Kalamazoo, Michigan, USA)
was administered at a dose of 3 mg/100 g body weight in 50
nephrotic rats and 50 control rats every other day for 20 days
[161. Ten rats from each group were sacrificed on days 0, 2, 8,
14 and 20. The kidneys were immediately removed and glomer-
uli were isolated by sieving through size 60, 150 and 200
meshes. Decapsulated glomeruli were collected from the top of
the 200-mesh sieve for RNA extraction. The preparation of
decapsulated glomeruli was greater than 90% pure and con-
tained very few tubular fragments. Remnant medulla was also
collected for RNA extraction. Twenty-four-hour urine speci-
mens were obtained from all rats in metabolic cages during the
course of the experiments. Urinary protein was measured by
the biuret method [17].
Extraction and quantitation of RNA
Total RNA was extracted from glomeruli and medulla by the
acid guanidinium thiocyanate-phenol chloroform extraction
method 1181. Isolated glomeruli from ten rats were mixed and
used for RNA extraction. Total RNA concentration was deter-
mined spectrophotometrically at 260 nm and 280 nm. RNA
samples (15 xg) were denatured and electrophoresed through
0.7% agarose gels containing 2.2 M formaldehyde, and trans-
ferred by capillary blotting onto nylon filters (Gene Screen,
New England Nuclear, Boston, Massachusetts, USA) [19. 201.
Before transferring the samples onto the nylon membrane,
ethidium-stained gels were visualized under ultraviolet illumi-
nation to determine the position of 28s and l8s ribosomal RNA
bands to assess the integrity of RNA and verify that equal
amounts of RNA were loaded. RNA was fixed to the filter by
ultraviolet irradiation for five minutes at 254 nm. In addition, we
performed dot blot analysis to ensure the reliability of Northern
blot analysis. Several two-fold dilutions of RNA were applied to
nylon filters using a 96-well vacuum manifold. RNA was fixed
to the filter by ultraviolet irradiation for five minutes at 254 nm.
Hybridization was carried out in 1% BSA, 7% SDS, 0.5 M
NaH2PO4, 1 mrvi EDTA and 100 sg/ml sonicated salmon sperm
DNA for 20 hours at 65°C [19]. Filters were washed three times
in 0.5% BSA, 5% SDS, 40 mrvi NaH2PO4 and 1 mM EDTA at
65°C, followed by three washes in 1% SDS, 40 mM NaH2PO4
and 1 mM EDTA at 65°C [19]. Filters were then exposed to
Kodak X-OMAT-AR film (Eastman Kodak, Rochester, New
York, USA) at —70°C with the aid of intensifying screens for 6
hours to 7 days. Relative intensities of bands on autoradiograms
were quantified by the Scanning Shimadzu CS-9000 densitom-
eter (Shimadzu Manufacturing, Kyoto, Japan).
cDNA probe
Clones for the al chain of type IV collagen (pFAC) and
laminin A (e3), Bi (p24) and B2 (p7) chains were isolated from
a cDNA library constructed from differentiated F9 teratocarci-
noma cell mRNA as previously reported [7, 20—22]. The $-actin
cDNA probe was provided by Dr. D.W. Cleveland, Johns
Hopkins University School of Medicine (Baltimore, Maryland,
USA) [23]. The cDNA clones for the core protein of basement
Time, days
Fig. 1. Urinary protein excretion in control (A) and PAN-nephrotic
rats with (0) or without (•) methyiprednisolone treatment. Means
standard deviation are indicated.
membrane heparan sulfate proteoglycan (clones 7, 54 and 72)
were provided by Dr. D.M. Noonan, National Institute of
Dental Research (Bethesda, Maryland, USA) [241. Clones for
the al chain of type I collagen and al chain of type III collagen
were provided by Dr. Y. Yamada, National Institute of Dental
Research (Bethesda, Maryland, USA) [6].
The cDNA inserts were excised and labeled by using a
Random Primed cDNA Labeling Kit (Boehringer-Mannheim-
Yamanouchi K.K., Tokyo, Japan) with 32P-deoxynucleotides
(New England Nuclear, Boston, Massachusetts, USA) to a
specific activity of l0 cpm/g [25].
Statistics
Statistical calculations were performed by one-way analysis
of variance.
Results
Urinary protein excretion
The urinary excretion of protein is shown in Figure 1. Protein
excretion of control rats remained within 14.8 6.3 mg/day
throughout the experimental period (20 days). PAN-treated rats
showed proteinuria within four days after PAN injection. Pro-
teinuria reached a peak on day 8 (210.6 38.4 mg/day) and then
declined to the control level by day 20. In PAN-nephrotic rats
administered 3 mg/l00 g body weight of MPSL, the urinary
protein level was ameliorated as shown in Figure 1 (100.4
22.8 mg/day on day 8).
mRNA analysis
On day 2, before proteinuria appeared, mRNA levels for the
ctl (IV) chain and laminin Bl and B2 chains were already
increased, and mRNA levels for HSPG were decreased in
PAN -nephrotic glomeruli. On day 8, in the nephrotic stage, the
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Fig. 2. Northern blot analysis of mRNA for /3-actin (A), aI chain of collagen IV(B), A chain of laminin (C), Bi chain of laminin (D), B2 chain
of laminin (E) and HSPG (clone 7) (F) in glomeruli. Lanes 1-5: control glomeruli on days 0, 2, 8,1 4, and 20, respectively. Lanes 6-10: PAN
nephrotic glomeruli with methyiprednisolone treatment on days 0, 2, 8, 14 and 20, respectively. Lanes 11-15: PAN nephrotic glomeruli on days
0, 2, 8, 14 and 20, respectively. Total cellular RNA was extracted and transferred onto a nylon membrane, hybridized with specific cDNA probe
and quantitated as in the experimental methods. Data are expressed as a percentage of the control glomeruli on day 0. The means standard error
are based on observations for 10 individual rats. Symbols are: (0) control; (A) PAN + MPSL; (•) PAN; * < 0.05; ** < 0.01; < 0.001.
glomerular mRNA levels for the al (IV) chain and laminin BI
and B2 chains were increased significantly. On day 14, mRNA
levels for the al (IV) chain and laminin BI and B2 chains
declined, while the HSPG mRNA level increased. On day 20, in
the remission stage of PAN nephrosis, mRNA levels for the al
(IV) chain and laminin BI and B2 chains in the glomeruli were
decreased markedly, but were still higher than those of con-
trols. In contrast, the HSPG mRNA level was increased to the
control level. mRNA levels for the al (I) chain and al (III)
chain showed little change in glomeruli of PAN nephrosis
throughout the experimental period.
These abnormal mRNA levels for the al (IV) chain, laminin
BI and B2 chains, and HSPG in glomeruli of PAN nephrosis
were ameliorated by treatment with MPSL (Fig. 2). In contrast,
mRNA levels for the al (I) chain and al (III) chain were not
affected by MPSL treatment (Fig. 3).
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The mRNA levels for these genes in glomeruli of control rats
decreased with time, whereas the 13-actin mRNA level in
glomeruli exhibited little change in control and PAN-nephrotic
rats with or without MPSL treatment (Fig. 2). Laminin A
mRNA was not detected in glomeruli of control or PAN-
nephrotic rats with or without MPSL treatment, except on the
eighth day of PAN nephrosis (Fig. 2). Glomerular mRNA levels
for these basement membrane components of control rats
treated with MPSL were similar to those of control rats without
MPSL treatment.
In addition, we examined the medullary mRNA levels for the
a! (IV) and laminin A, Bl and B2 chains and HSPG in PAN
nephrosis with or without MPSL treatment. mRNA levels for
the al (IV) chain and laminin A, BI and B2 chains and HSPG
decreased with time in medulla of the control and PAN-
nephrotic rats with or without MPSL treatment (Fig. 4). There
were no differences in the mRNA levels of these genes in
medulla between PAN nephrotic and control rats. However,
mRNA levels for the a! (I) chain and al (III) chain increased
significantly in the medulla of PAN nephrotic rats in the
nephrotic stage, and the elevated mRNA expression of these
genes was ameliorated by treatment with MPSL (Fig. 5). The
/3-actin mRNA level in medulla showed little change in control
and PAN nephrotic rats with or without MPSL treatment.
Medullary mRNA levels for these basement membrane compo-
nents, interstitial collagens and /3-actin of control rats treated
with MPSL were similar to those of control rats without MPSL
treatment.
The results of dot blot analysis coincided with those of
Northern blot analysis (data not shown).
Discussion
Our studies indicated that the gene expression of basement
membrane components in the glomeruli of PAN nephrosis was
altered and that the mRNA expression of these genes in medulla
was similar in PAN nephrotic and control rats. Heparan sulfate
proteoglycan (HSPG), the major proteoglycan of the glomerular
basement membrane, has been identified as one of the biochem-
ical determinants of the charge-selective permeability of the
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Fig. 3. Northern blot analysis of mRNA for a! chain of collagen I (A) and a! chain of collagen III (B) in glomeruli. Lanes 1-5: control glomeruli
on days 0, 2, 8, 14 and 20, respectively. Lanes 6-10: PAN nephrotic glomeruli with methylprednisolone treatment on days 0, 2, 8, 14 and 20,
respectively. Lanes 11-15: PAN nephrotic glomeruli on days 0, 2, 8, 14 and 20, respectively. Data are expressed as a percentage of the control
glomeruli on day 0. Symbols are: (0) control; (ti) PAN ÷ MPSL; (•) PAN.
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Fig. 4. Northern blot analysis of mRNA for /3-actin (A), al chain of collagen IV (B), A chain of laminin (C),BI chain of laminin (D), B2 chain
of laminin (F) and IISPG (clone 7) (F) in medulla, Lanes I-5: control medulla on days 0, 2, 8, 14 and 20, respectively. Lanes 6-10: PAN nephrotic
medulla with methyiprednisolone treatment on days 0, 2, 8, 14 and 20, respectively. Lanes 11-15: PAN nephrotic medulla on days 0, 2, 8, 14 and
20, respectively. Data are expressed as a percentage of the control medulla on day 0. Symbols are: (0) control; (Li) PAN + MPSL; (•) PAN.
glomerular capillary [26]. Fishman and Karnovsky [27] sug-
gested that glomerular epithelial cells are an immediate site of
PAN toxicity, and showed decreased secretion of glucosamine
and sulfate by cultured glomerular epithelial cells. Kasinath et
al [281 demonstrated by a quantitative immunoperoxidase
method that PAN caused a 28% reduction in the core protein of
HSPG in epithelial cells. It is likely that glomerular epithelial
cell damage by PAN leads to decreased glomerular HSPG
synthesis. The lower mRNA levels for HSPG in glomeruli of
PAN nephrosis in our studies may be associated with a reduced
rate of synthesis. As PAN did not affect HSPG mRNA levels in
medulla, it is probable that the effect of PAN on HSPG mRNA
is specific to glomeruli. Mahan et al [291 reported that glomer-
ular capillary wall structure and epithelial cell morphologic
characteristics are altered within four hours of PAN exposure,
and that foot process fusion and widespread epithelial cell
changes occur slightly later.
To determine whether mRNA changes are the effect of PAN
or the result of proteinuria, we measured mRNA levels four
hours after PAN injection (data not shown). mRNA levels for
the basement membrane components were already altered in
the early stage, suggesting that the alteration of basement
membrane genes in glomeruli of PAN nephrosis is due to PAN
rather than proteinuria.
Laminin A chain mRNA expression was detected in the
medulla of controls and PAN nephrotic rats with or without
MPSL treatment, but not in glomeruli of PAN nephrosis except
for the eighth day, the peak of proteinuria. Mohan and Spiro
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Fig. 5. Northern blot analysis of mRNA for
cr1 chain of collagen I (A) and cxl chain of
collagen III (B) in medulla. Lanes 1-5: control
medulla on days 0, 2, 8, 14 and 20,
respectively. Lanes 6-10: PAN nephrotic
medulla with methylprednisolone treatment on
days 0, 2, 8, 14 and 20, respectively. Lanes
11-IS: PAN nephrotic medulla on days 0, 2, 8,
14 and 20, respectively. Data are expressed as
a percentage of the control medulla on day 0.
Symbols are: (0) control; () PAN + MPSL;(•) PAN; * < 0.05; ** < 0.01;
0.001.
[30] showed that the renal glomerulus contains predominantly
laminin B chains. They considered that the small levels of
laminin A chain in tissues were probably due to preferential
proteolytic degradation. Kleinman et at [7] reported that mRNA
for the laminin A chain was not expressed in the kidney. Our
data indicated that mRNA for the laminin A chain was ex-
pressed predominantly in medulla, rather than in glomeruli, and
that the mRNA levels of their laminin chains were not coordi-
nately regulated in glomeruli. Our data also showed that mRNA
levels for basement membrane components of control rats
decreased with age, a finding that was in agreement with
previous reports [7, 8, 31, 32].
mRNA levels for interstitial collagens including cxl (I) chain
and a! (III) chain were detected in both the medulla and
glomeruli of controls and PAN nephrotic rats. PAN did not
affect glomerular mRNA levels for cr1 (I) chain or cr1 (III) chain.
Several immunofluorescence studies have shown that type III
collagen is present in the interstitium and blood vessels of the
normal kidney, but not in any structures of the glomeruli
[33—351. A possible explanation for these conflicting results
could be low immunofluorescence sensitivity, posttranscrip-
tional inhibition or increased turnover. Cultured mesangial cells
have been demonstrated to produce not only basement mem-
brane components but also type I and type III collagens [36,
37]. Recently Ohyama et al [15] showed that cultured mesangial
cells expressed mRNA for at (I) chain, cr1 (III) chain and cr1
(IV) chain. We also recognized mRNA expression for cxl (I)
chain and cxl (III) chain as well as at (IV) chain, laminin chains
and HSPG in cultured mesangial cells (unpublished data). It is
therefore possible that intrinsic glomerular cells are responsible
for type I collagen and type III collagen mRNA production.
Further studies aimed at determining which cells synthesize
collagens I, III and IV, taminin chains and HSPG at different
time points in PAN nephrosis and controls would require a
different approach, for example, in situ hybridization.
Significant morphological changes in the renal interstitium of
PAN nephrosis have been reported [13]. Our results also
indicated that PAN affected the renal interstitium and mRNA
levels for interstitial collagens.
Moreover, we studied the effect of MPSL on the gene
expression of basement membrane components and interstitial
collagens in PAN nephrosis. It is well known that morpholog-
ical changes in glomerular epithelial cells in PAN rats treated
with glucocorticoid improve markedly and proteinuria de-
creases significantly [12]. Glucocorticoid has been reported to
induce qualitative and quantitative changes in glycosaminogly-
can synthesis in nonrenal tissues [38, 39]. Recently, Kasinath et
at [14] showed that dexamethasone increased the HSPG core
protein content of cultured glomerular epithelial cells in vitro.
Our results indicate that MPSL probably ameliorated the dam-
aged glomerular epithelial cells and increased HSPG mRNA
levels in glomeruli of PAN nephrosis. However, MPSL did not
affect HSPG mRNA levels in glomeruli of control rats or in
medulla of PAN treated and control rats in vivo.
The mechanism by which glucocorticoid inhibits collagen
mRNA levels appears to be complicated. Sterling et at [40]
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suggested that the decline in procollagen synthesis in cells or
tissues treated with glucocorticoids may be a reflection of the
decrease in the total cellular content of procollagen-specific
mRNA sequences and that glucocorticoids may regulate procol-
lagen production primarily at the level of mRNA. Studies of the
molecular effects of dexamethasone on collagen synthesis have
shown that dexamethasone decreases type I collagen mRNA
[41, 421. In dermal fibroblasts, hydrocortisone reduced the
concentration of mRNAs for a! (I), a2 (I), a! (III) and a2 (V)
collagen genes [43]. Weiner et al demonstrated that in an in vivo
model of fibrosis dexamethasone produced transcriptional inhi-
bition of type I collagen gene expression [44], and cells treated
with dexamethasone had decreased type I and type IV collagen
mRNA steady-state levels due in part to diminished transcrip-
tion rates of the gene 145]. Our data indicate that MPSL reduced
glomerular mRNA levels for al (IV) chain and laminin chains as
well as medullary mRNA levels for a! (I) chain and al (III)
chain in PAN nephrosis, while MPSL did not affect these
mRNA levels in control glomeruli and medulla. Although the
mechanism by which glucocorticoid reduces collagen mRNA
levels remains unclear, a decrease in the transcription [45,46]
and lability of collagen mRNAs [41, 42] have been reported.
We previously reported that there is little difference in the
pattern, distribution and intensity of staining of type IV colla-
gen, laminin and HSPG between PAN nephrosis and controls
[11]. We were unable to show by the immunofluorescence
method that changes in mRNA reflected altered protein expres-
sion. In the present study, MPSL did not alter the pattern,
distribution or intensity of these proteins as determined by the
immunofluorescence method (data not shown). This may reflect
a low turnover rate of existing ECM proteins which could mask
subtle protein changes, low immunofluorescence sensitivity or
abnormal posttranscriptional control. Further studies are also
needed to examine the possible effects of MPSL on posttran-
scriptional control of matrix biosynthesis, including message
stability and protein degradation, in PAN nephrosis.
PAN nephrosis is a complex disease which exhibits a bipha-
sic pattern of protein excretion [47, 48]. Minimal glomerular
lesions and interstitial cellular infiltrates are observed during
the first phase, whereas glomerulosclerosis is evident later
during the second phase [47, 48]. However, the effects of MPSL
on glomerular or medullary mRNA for ECM components in the
second phase of PAN nephrosis remain unknown.
Diamond et a! [49] demonstrated by double immunohisto-
chemical labeling studies that the source of the antigenically
expressed tumor necrosis factor and interleukin I in the gb-
meruli of acute PAN nephrosis is the glomerular macrophage.
Therefore, the beneficial effect of MPSL on proteinuria during
the early phase of the disease may be related to the inhibition of
inflammatory cellular infiltrates and of cytokine generation. We
showed that MPSL did not affect mRNA levels for ECM
components in control glomeruli and medulla. This suggests
that MPSL may prevent the synthesis of cytokines that regulate
the expression of genes for ECM components.
In summary, we demonstrated that glomerular mRNA levels
for a! (IV) chain and laminin chains increased while those for
HSPG decreased significantly in PAN nephrosis, that medullary
mRNA levels for a! (I) chain and al (III) chain increased
markedly at the peak of proteinuria in PAN nephrosis and that
abnormal mRNA levels persisted to day 20. This abnormal gene
expression was partially ameliorated by MPSL treatment.
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